Ameriprise’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-121,267
Closed -$632K 3999
2023
Q1
$632K Sell
121,267
-104,539
-46% -$751K ﹤0.01% 3334
2022
Q4
$1.68M Buy
225,806
+99,340
+79% +$896K ﹤0.01% 2887
2022
Q3
$1.68M Sell
126,466
-36,763
-23% -$439K ﹤0.01% 2858
2022
Q2
$1.25M Sell
163,229
-1,705
-1% -$14.3K ﹤0.01% 3023
2022
Q1
$1.67M Buy
164,934
+3,917
+2% +$35.8K ﹤0.01% 2991
2021
Q4
$1.16M Buy
+161,017
New +$881K ﹤0.01% 3189

Other funds holding SRTS

Ameriprise's SRTS Position: Q2 2023 in Review

Ameriprise sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 121,267 shares — an estimated $632K sold.

Ameriprise first reported a position in SRTS in Q4 2021 and held it in 6 quarters. The position peaked at $1.68M in Q3 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

  • Ameriprise reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
  • Ameriprise sold 121,267 Sensus Healthcare shares in Q2 2023, an estimated $632K.
  • Ameriprise first reported a position in Sensus Healthcare in Q4 2021 and held it in 6 quarters.
  • Ameriprise's Sensus Healthcare position peaked at $1.68M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Ameriprise's 13F filing for Q2 2023, filed 14 Aug 2023.